Navigation Links
Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia
Date:4/21/2009

ed to treat epilepsy. They found the two drugs worked together to dramatically stimulate cell death.

"We considered an old drug for a new use," Dr. Ge said. "It looks like the increased drug activity or synergy is not due to the transport or delivery of clofarabine, but to enhanced cell death. We were so pleased with the results."

AML afflicts mostly adults -- about 10,000 new cases each year -- and strikes older children. Acute lymphoblastic leukemia usually affects children between the ages of 2 to 5 and is generally easier to treat. Treatment advancements for AML, however, have been less successful.

Dr. Ge said researchers at Karmanos discovered the synergy between VPA and clofarabine only a few months ago, though departmental research has spanned some 15 years in the field of treating childhood leukemias. The current research represents a unique partnership between Dr. Ge, his Karmanos colleagues, and Jeffrey W. Taub, M.D., a pediatric oncologist at Children's Hospital of Michigan, also in Detroit.

Dr. Ge expects that their findings will move into the clinical phase in the next few years. St. Jude Children's Research Hospital in Memphis, Tenn. Is now conducting its own clinical drug trial studying the combined effects of VPA and cytarabine to treat newly diagnosed AML patients 21 years old and younger.

"This is truly translational research," Dr. Ge said. "We really want to translate what we do in the laboratory to the clinic and hopefully save more lives."

Located in mid-town Detroit, MI, the Barbara Ann Karmanos Cancer Institute is one of 40 National Cancer Institute-designated comprehensive cancer centers in the United States. Caring for more than 6,000 new patients annually on a budget of $216 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, the Karmanos Cancer Institute is among the na
'/>"/>

SOURCE Barbara Ann Karmanos Cancer Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference
2. DNA Vaccine Developed at the Karmanos Cancer Institute Fights HER2-Positive Cancers
3. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
4. Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients
5. Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women
6. Karmanos Researchers Study the Impact of Galectin-3 on Breast Cancer Disparity in Caucasian and Asian Women
7. Karmanos Researchers Find Non-Toxic Agents Added to Conventional Chemotherapy Decrease Survival of Colon Cancer Cells
8. First Candidate from Esperances Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept
9. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
10. Genes Identified That Enhance Tumor Cell Sensitivity to CTIs Cancer Drug Brostallicin
11. Muscadine Grape Skin Dietary Supplement Protects against Cancer Therapy Radiation Side Effects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... ( www.medscope.org ), the leading provider of medical alert ... World magazine Connected World Award for its new ... used anywhere, anytime. The nomination was made by RacoWireless, ... MedScope, Landon Garner , Director of Marketing of ...
(Date:1/23/2015)...  Pete Rose, baseball,s all-time hits leader, is the new spokesperson ... Ducere Pharma has announced. "Pete,s a Hall of ... him on board with Myoflex," said Ducere Pharma Chief Executive ... who is known across all generations. The passion and intensity ...
(Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
Breaking Medicine Technology:MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Pete Rose bets on Myoflex to relieve aches and pains 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... , , IRVINE, Calif. ... Fabio Gratton , Chief Innovation Officer at Ignite Health, Dr. ... at the Food and Drug Administration,s Division of Drug Marketing, ... is requesting additional information from the public, including pharmaceutical companies and ...
... , , ANDOVER, Mass. , ... of Pro Medicus Ltd. (ASX: PME), announces today John Danahy ... Services. With over 17 years in the healthcare IT industry, Johns ... Danahy was previously VP Sales of Medsphere where he managed the ...
Cached Medicine Technology:FDA Official States Need for Greater Data from Public Stakeholders and Industry to Inform the Guidance Process for use of Internet and Social Media in the Promotion of FDA-regulated Medical Products 2FDA Official States Need for Greater Data from Public Stakeholders and Industry to Inform the Guidance Process for use of Internet and Social Media in the Promotion of FDA-regulated Medical Products 3FDA Official States Need for Greater Data from Public Stakeholders and Industry to Inform the Guidance Process for use of Internet and Social Media in the Promotion of FDA-regulated Medical Products 4FDA Official States Need for Greater Data from Public Stakeholders and Industry to Inform the Guidance Process for use of Internet and Social Media in the Promotion of FDA-regulated Medical Products 5FDA Official States Need for Greater Data from Public Stakeholders and Industry to Inform the Guidance Process for use of Internet and Social Media in the Promotion of FDA-regulated Medical Products 6Visage Imaging Names John Danahy as General Manager North America, Sales and Services 2
(Date:1/22/2015)... Deer Path of Huntley -- a BMA affordable assisted ... 3 p.m. to 4 p.m. on Feb. 13. , The community, ... adults with physical disabilities between the ages of 22 and 64. ... and sweetheart-themed karaoke. , For more information about the event or ...
(Date:1/22/2015)... its top dressmaking technologies, has been a leading dress supplier ... latest designs of wedding dresses and launching a site-wide promotion ... the fresh new products are designed for 2015, and they ... All the clothes from LunaDress follow up with the latest ...
(Date:1/22/2015)... TN (PRWEB) January 22, 2015 Gabe’s Chemo Duck ... Duck App, the first app ever created for kids with cancer. ... Apple phones and devices, is filled with enjoyable games to help ... and treatments. The free app helps to keep kids entertained, educated ...
(Date:1/22/2015)... Houston, TX (PRWEB) January 22, 2015 The ... Pro Bodybuilder Ben Pakulski to increase lean muscle by up ... This has caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting ... shows that it is a step-by-step, scientific diet formula that ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 AngelWeddingDress, the ... of 2015 maternity wedding dresses. View website ... are looking for maternity wedding dresses online for a ... gowns with high quality for them. Its maternity wedding ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2
... previous poll, Democratic contender,still enjoys broad support, ... waning days of the,2008 Presidential Campaign, healthcare providers ... McCain (R-Ariz.) by a sizable margin,according to an ... )., (Photo: http://www.newscom.com/cgi-bin/prnh/20081103/NY43443 ), ...
... 3 /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. (TSX: PMD; ... Stock Exchange ("TSX") that it is reviewing the eligibility ... TSX., The Company is being reviewed under the ... to comply with all requirements for continued,listing. If the ...
... tumor sites were cervix, head and neck, government study ... estimated 25,000 cases of cancers associated with human papillomavirus ... Columbia between 1998 and 2003, U.S. officials reported Monday. ... more than 100 different types, more than 30 of ...
... less safe than Cox-1 drugs, like naproxen, study says ... risk of heart attack that comes with the use ... is directly related to the specific pain-causing molecule they ... a significant correlation between the degree of inhibition in ...
... ongoing efforts to educate the public about HIV, a ... Harvard University and Children,s Hospital Boston has found that ... about spreading HIV in the home. , The qualitative ... including minor children, in families with an HIV-infected parent ...
... Health Enhancement Systems Studies (CHESS) has been awarded a ... division of the National Institutes of Health (NIH), to ... research. , The five-year, $8.6 million grant for the ... II) will investigate problems associated with cancer communication in ...
Cached Medicine News:Health News:Election-Eve MedPage Today(R) Poll Gives Obama Double-Digit Lead Among Clinicians 2Health News:Election-Eve MedPage Today(R) Poll Gives Obama Double-Digit Lead Among Clinicians 3Health News:Listing Review initiated by the Toronto Stock Exchange 2Health News:U.S. Reported 25,000 Cases of HPV-Related Cancers Annually 2Health News:Study Sheds Light on Painkillers' Heart Risk 2Health News:Study Sheds Light on Painkillers' Heart Risk 3Health News:Study finds fears of HIV transmission in families with infected parent 2Health News:Center for Health Enhancement Systems Studies awarded $8.6 million NIH grant 2
Inquire...
... Fractionation, Proteins and Viruses • ... with fixed-angle rotor • Spin ... 85 mL • Operating temperature ... C • Rotors certified by ...
... to 10 inches/ 25 cm thinner than other benchtop ... X-22 Series is the space-saving multipurpose solution for your ... 46 cm wide • 11 Rotor Library • Achieve ... to Spin 1.5 mL & PCR+ Tubes: 24-place ...
... tradition of progressive centrifuge design and manufacturing, ... Centra-CL3 and Centra-CL3R (refrigerated) general purpose models ... Quality Control Over Sample Preparation , The ... to 99 protocols and has speed and ...
Medicine Products: